Cargando…
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes
INTRODUCTION: We aimed to assess the feasibility of determining Alzheimer's disease cerebrospinal fluid (CSF) cut points in small samples through comparison with amyloid positron emission tomography (PET). METHODS: Twenty-three individuals (19 patients, four controls) had CSF measures of amyloi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691234/ https://www.ncbi.nlm.nih.gov/pubmed/26835507 http://dx.doi.org/10.1016/j.dadm.2015.10.001 |
_version_ | 1782407124353024000 |
---|---|
author | Weston, Philip S.J. Paterson, Ross W. Modat, Marc Burgos, Ninon Cardoso, Manuel J. Magdalinou, Nadia Lehmann, Manja Dickson, John C. Barnes, Anna Bomanji, Jamshed B. Kayani, Irfan Cash, David M. Ourselin, Sebastien Toombs, Jamie Lunn, Michael P. Mummery, Catherine J. Warren, Jason D. Rossor, Martin N. Fox, Nick C. Zetterberg, Henrik Schott, Jonathan M. |
author_facet | Weston, Philip S.J. Paterson, Ross W. Modat, Marc Burgos, Ninon Cardoso, Manuel J. Magdalinou, Nadia Lehmann, Manja Dickson, John C. Barnes, Anna Bomanji, Jamshed B. Kayani, Irfan Cash, David M. Ourselin, Sebastien Toombs, Jamie Lunn, Michael P. Mummery, Catherine J. Warren, Jason D. Rossor, Martin N. Fox, Nick C. Zetterberg, Henrik Schott, Jonathan M. |
author_sort | Weston, Philip S.J. |
collection | PubMed |
description | INTRODUCTION: We aimed to assess the feasibility of determining Alzheimer's disease cerebrospinal fluid (CSF) cut points in small samples through comparison with amyloid positron emission tomography (PET). METHODS: Twenty-three individuals (19 patients, four controls) had CSF measures of amyloid beta (Aβ)(1–42) and total tau/Aβ(1–42) ratio, and florbetapir PET. We compared CSF measures with visual and quantitative (standardized uptake value ratio [SUVR]) PET measures of amyloid. RESULTS: Seventeen of 23 were amyloid-positive on visual reads, and 14 of 23 at an SUVR of ≥1.1. There was concordance (positive/negative on both measures) in 20 of 23, of whom 19 of 20 were correctly classified at an Aβ(1–42) of 630 ng/L, and 20 of 20 on tau/Aβ(1–42) ratio (positive ≥0.88; negative ≤0.34). Three discordant cases had Aβ(1–42) levels between 403 and 729 ng/L and tau/Aβ(1–42) ratios of 0.54–0.58. DISCUSSION: Comparing amyloid PET and CSF biomarkers provides a means of assessing CSF cut points in vivo, and can be applied to small sample sizes. CSF tau/Aβ(1–42) ratio appears robust at predicting amyloid status, although there are gray zones where there remains diagnostic uncertainty. |
format | Online Article Text |
id | pubmed-4691234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-46912342016-01-29 Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes Weston, Philip S.J. Paterson, Ross W. Modat, Marc Burgos, Ninon Cardoso, Manuel J. Magdalinou, Nadia Lehmann, Manja Dickson, John C. Barnes, Anna Bomanji, Jamshed B. Kayani, Irfan Cash, David M. Ourselin, Sebastien Toombs, Jamie Lunn, Michael P. Mummery, Catherine J. Warren, Jason D. Rossor, Martin N. Fox, Nick C. Zetterberg, Henrik Schott, Jonathan M. Alzheimers Dement (Amst) Neuroimaging INTRODUCTION: We aimed to assess the feasibility of determining Alzheimer's disease cerebrospinal fluid (CSF) cut points in small samples through comparison with amyloid positron emission tomography (PET). METHODS: Twenty-three individuals (19 patients, four controls) had CSF measures of amyloid beta (Aβ)(1–42) and total tau/Aβ(1–42) ratio, and florbetapir PET. We compared CSF measures with visual and quantitative (standardized uptake value ratio [SUVR]) PET measures of amyloid. RESULTS: Seventeen of 23 were amyloid-positive on visual reads, and 14 of 23 at an SUVR of ≥1.1. There was concordance (positive/negative on both measures) in 20 of 23, of whom 19 of 20 were correctly classified at an Aβ(1–42) of 630 ng/L, and 20 of 20 on tau/Aβ(1–42) ratio (positive ≥0.88; negative ≤0.34). Three discordant cases had Aβ(1–42) levels between 403 and 729 ng/L and tau/Aβ(1–42) ratios of 0.54–0.58. DISCUSSION: Comparing amyloid PET and CSF biomarkers provides a means of assessing CSF cut points in vivo, and can be applied to small sample sizes. CSF tau/Aβ(1–42) ratio appears robust at predicting amyloid status, although there are gray zones where there remains diagnostic uncertainty. Elsevier 2015-11-02 /pmc/articles/PMC4691234/ /pubmed/26835507 http://dx.doi.org/10.1016/j.dadm.2015.10.001 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Neuroimaging Weston, Philip S.J. Paterson, Ross W. Modat, Marc Burgos, Ninon Cardoso, Manuel J. Magdalinou, Nadia Lehmann, Manja Dickson, John C. Barnes, Anna Bomanji, Jamshed B. Kayani, Irfan Cash, David M. Ourselin, Sebastien Toombs, Jamie Lunn, Michael P. Mummery, Catherine J. Warren, Jason D. Rossor, Martin N. Fox, Nick C. Zetterberg, Henrik Schott, Jonathan M. Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes |
title | Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes |
title_full | Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes |
title_fullStr | Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes |
title_full_unstemmed | Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes |
title_short | Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes |
title_sort | using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes |
topic | Neuroimaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691234/ https://www.ncbi.nlm.nih.gov/pubmed/26835507 http://dx.doi.org/10.1016/j.dadm.2015.10.001 |
work_keys_str_mv | AT westonphilipsj usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT patersonrossw usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT modatmarc usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT burgosninon usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT cardosomanuelj usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT magdalinounadia usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT lehmannmanja usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT dicksonjohnc usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT barnesanna usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT bomanjijamshedb usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT kayaniirfan usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT cashdavidm usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT ourselinsebastien usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT toombsjamie usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT lunnmichaelp usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT mummerycatherinej usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT warrenjasond usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT rossormartinn usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT foxnickc usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT zetterberghenrik usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes AT schottjonathanm usingflorbetapirpositronemissiontomographytoexplorecerebrospinalfluidcutpointsandgrayzonesinsmallsamplesizes |